Cilastatin Sodium

CAS 81129-83-1 4 current records 4 historicalSmall Molecule

Who holds supplier records for Cilastatin Sodium? 4 organisations hold a current record for Cilastatin Sodium: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), China (1) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cilastatin Sodium: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cilastatin-sodium

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cilastatin Sodium. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • Shandong Anhong Pharmaceutical Co., Ltd.
    Active DMF 42234 · latest filing Jul 2025
    ChinaCEP Company GMP cert on record
  • ACS DOBFAR SPA
    Active DMF 21594 · latest filing May 2008
    Italy Company GMP cert on record
  • UNIMARK REMEDIES LTD
    Active DMF 28365 · latest filing Jun 2014
    India
  • Sun Pharmaceutical Industries Limited
    Inactive DMF 20089 · latest filing Dec 2006
    IndiaCEP Company GMP cert on record
Need Cilastatin Sodium sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Cilastatin Sodium, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 3 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. DezhouCN
CEP 2025-103 - Rev 00
Cilastatin sodium, Sterile
Nov 2025Inspected Nov 2025
Greece
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
R1-CEP 2009-179 - Rev 02
Cilastatin sodium, Sterile
Feb 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Cilastatin Sodium are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • AURONEXT PHARMA PRIVATE LTD
    Inactive DMF 28929 · filed Jan 2015
  • Germany · Inactive DMF 23307 · filed Nov 2009
  • PFIZER HEALTHCARE INDIA PVT LTD
    Inactive DMF 21698 · filed Jul 2008
  • Taiwan · Inactive DMF 19938 · filed Oct 2006

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Cilastatin Sodium is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201057).

Chemical identity

IUPAC name
sodium (Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate
Canonical SMILES
CC1(C[C@@H]1C(=O)N/C(=C\CCCCSC[C@@H](C(=O)O)N)/C(=O)[O-])C.[Na+]
InChIKey
QXPBTTUOVWMPJN-QBNHLFMHSA-M
Synonyms
Cilastatin sodium, Cilastatin sodium component of mk-7655a, Cilastatin sodium component of primaxin, Cilastatin sodium component of recarbrio, Cilastatin sodium salt, MK-791

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cilastatin Sodium?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Cilastatin Sodium: Shandong Anhong Pharmaceutical Co., Ltd. (China), ACS DOBFAR SPA (Italy), UNIMARK REMEDIES LTD (India) and Sun Pharmaceutical Industries Limited (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cilastatin Sodium Drug Master Files are active?

Shandong Anhong Pharmaceutical Co., Ltd. (DMF 42234), ACS DOBFAR SPA (DMF 21594) and UNIMARK REMEDIES LTD (DMF 28365). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cilastatin Sodium records mean?

4 organisations have only inactive Type II DMFs for Cilastatin Sodium. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cilastatin Sodium have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Cilastatin Sodium on the EDQM register, including SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou (CN) and SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Cilastatin Sodium supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cilastatin Sodium?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.